Life Sciences Tools and Services
Company Overview of PureTech Health plc
PureTech Health plc, a science-driven healthcare company, focuses on developing technologies that seek to address significant healthcare markets. The company, through its subsidiaries and operating companies, engages in developing microbiome immune system drug-discovery platform and drug candidates for the treatment of immune-mediated diseases; and products that seek to induce weight loss and potentially enhance glycaemic control through an orally administered capsule. It is also developing technology and products for the screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for ps...
501 Boylston Street
Boston, MA 02116
Founded in 2015
Key Executives for PureTech Health plc
Chief Executive Officer, Founder and Executive Director
Total Annual Compensation: $614.9K
Executive Vice President, Legal, Finance and Operations and Executive Director
Total Annual Compensation: $410.4K
Compensation as of Fiscal Year 2014.
PureTech Health plc Key Developments
PureTech Names Marko Ahtisaari as CEO
Jul 15 15
PureTech announced that it has named a former Nokia executive as its first CEO. Marko Ahtisaari, who served as head of design for the Nokia a few years back, was named to head the startup less than a year after it was launched. Ahtisaari, 45, left his position at Nokia in 2013 after four years, a job he came into after Nokia bought the company he previously co-founded and led, a social networking service called Dopplr. Now, he is a Director's Fellow at the MIT Media Lab.
PureTech Health Announces Executive Changes
May 26 15
PureTech announced that Dame Marjorie Scardino, Chairman of the MacArthur Foundation and former CEO of Pearson, has been appointed to PureTech's Board of Directors in the role of Senior Independent Director and that current Board member Joi Ito, MIT Media Lab's Director, has been appointed Board Chairman. Dr. Ben Shapiro, PureTech's outgoing Chairman and co-founder, former Executive Vice President of Basic & External Research at Merck, will remain an active member of the Board. PureTech is also expanding its core team with the addition of Julie DiCarlo, former Head of Global Communications at Cubist Pharmaceuticals, as SVP of Communications and Investor Relations; and Spencer Ball, former Director of Executive Search/Talent Acquisition at PAREXEL, as Vice President of Talent Acquisition. Dame Marjorie Scardino served as Chief Executive of The Economist for 12 years and then from 1997 through 2012 was the Chief Executive of Pearson plc. She is currently the Chairman of The MacArthur Foundation and is also a member of the non-profit boards of Oxfam, The Royal College of Art, and The Carter Center, as well as the for-profit boards of Twitter, where she sits on the audit committee, and IAG (the holding company of British Airways, Iberia and other airlines). Dame Marjorie has received a number of honorary degrees, and in 2003 was dubbed a Dame of the British Empire. She is also a member of the Royal Society of the Arts in the UK and the American Association of Arts and Sciences. Dame Marjorie will be joining PureTech's existing Senior Partners and Board Members, Dr. Robert Langer, PureTech Co-founder and David H. Koch Institute Professor at MIT; Mr. Joi Ito, PureTech Chairman, MIT Media Lab Director and board member of Sony, the MacArthur Foundation, The New York Times, the Knight Foundation and Mozilla; Dr. Ben Shapiro, former EVP of Worldwide Basic and External Research at Merck; Dr. John LaMattina, former President of R&D at Pfizer Global Research and Development; Mr. Christopher Viehbacher, former CEO and member of the board of directors of Sanofi; Dr. H. Robert Horvitz, Nobel Laureate, David H. Koch Professor at MIT and Investigator, Howard Hughes Medical Institute; Dr. Raju Kucherlapati, Paul C. Cabot Professor in the Harvard Medical School Department of Genetics, co-founder of Millennium Pharmaceuticals and Abgenix, and Member of President Obama's Commission for the Study of Bioethical Issues; and Daphne Zohar, PureTech's Founder and CEO, recognized as a healthcare innovator and leader by The Boston Globe, MIT's Technology Review, Scientific American, BioWorld and others.
PureTech Announces Board Changes
May 26 15
PureTech announced that Dame Marjorie Scardino, chairman of the MacArthur Foundation and former CEO of Pearson, has been appointed to PureTech's board of directors in the role of senior independent director and that current board member Joi Ito, MIT Media Lab's director, has been appointed board chairman. Dr. Ben Shapiro, PureTech's outgoing chairman and co-founder, former executive vice president of Basic & External Research at Merck, will remain an active member of the Board. PureTech is also expanding its core team with the addition of Julie DiCarlo, former head of global communications at Cubist Pharmaceuticals, as SVP of communications and investor relations; and Spencer Ball, former director of executive search/talent acquisition at PAREXEL, as Vice president of talent acquisition. Dame Marjorie Scardino served as chief executive of the economist for 12 years and then from 1997 through 2012 was the chief executive of Pearson plc. and the owner of Penguin Books and The Financial Times Group. She is currently the chairman of the MacArthur Foundation and is also a member of the non-profit boards of Oxfam, The Royal College of Art, and The Carter Center, as well as the for-profit boards of Twitter, where she sits on the audit committee, and IAG (the holding company of British Airways, Iberia and other airlines).
Similar Private Companies By Industry
Recent Private Companies Transactions
April 21, 2015
|Tal Medical Inc.
January 9, 2015
October 20, 2014